9072 results about "Polyvinylpyrrolidone" patented technology

The present invention provides a dissolvable medical sealing device (3, 4; 6, 7; 9) for closing a wound in vessel. A sealing device (3, 4, 6, 7, 9) according to the invention is made of a material that dissolves by means of physical processes, rather than by means of chemical or biological processes. Such a sealing device (3, 4; 6, 7; 9) can be made of polyethylene glycol, polypropylene glycol, copolymers containing ethylene glycol and propylene glycol, polyvinyl alcohol or polyvinyl pyrolidone, or any combinations thereof.

A lubrication system is disclosed which minimizes friction and that is useful for application on the surface of a flexible portion of a medical device. Such a lubrication system includes a lubricant that is able to move when the flexible portion of the medical device flexes and is biocompatible and is not degraded by the application of alcohol or other conventional medical sterilizing and cleaning agents. The lubricant is bonded to the surface of the flexible portion of the medical device. The lubrication system may be used on an elastomeric septum, such as a silicone rubber elastomer. The lubricant coating may be any type of coating that can be chemically bonded to the elastomer, such as di-paraxylene, poly-(p-xylene), polytetrafluoroethylene, or polyvinylpyrrolidone.

An vivo biocompatible and bio-excretable lubricant and ultrasound coupling fluid or gel comprising polyvinylpyrrolidone (PVP) and/or polyvinyl alcohol (PVA). The inventive couplant fluid or gel comprises polyvinylpyrrolidone and/or polyvinyl alcohol solutions in water to which humectants such as alkylene glycols and/or polyalkylene glycols are added to achieve desired tactile and drying characteristics. Additionally, such fluids and gels may be prepared by addition of organic and inorganic cross-linkers.

An intradermal patch having a permeable backing coated with a polyvinylpyrrolidone-based hydrogel and containing one or more local anesthetics. The patch is breathable, non-irritating upon application and removal, soothing, and sterile. The patch is useful for treating the pain associated with non-intact skin indications.

Compositions comprising a glycosaminoglycan (e.g., a hyaluronan, hyaluronic acid, hyaluronate, sodium hyaluronate, dermatan sulfate, karatan sulfate, chondroitin 6-sulfate, heparin, etc.) in combination with at least one component selected from; i) polyglycols (e.g., polyethylene glycol), ii) long chain hydroxy polyanionic polysaccharides (e.g., dextran, sodium alginate, alginic acid, propylene glycol alginate, carboxymethyl cellulose and carboxyethyl cellulose, hydroxyl ethyl starch, hydroxyl propyl methyl cellulose, hydroxy propyl ethyl cellulose, hydroxy propyl cellulose, methyl cellulose, polylysine, polyhistidine, polyhydroxy proline, poly ornithine, polyvinyl pyrolidone, polyvinyl alcohol, chitosan, etc.) and iii) long chain Nitrogen containing polymers (e.g., Polylysine, Polyvinylpyrrolidone, and polyvinyl alcohol). The invention also includes methods for using such compositions (e.g., as substance delivery materials, tissue fillers or bulking agents, as moistening or hydrating agents, etc.)

A nonaqueous, single-phase vehicle that is capable of suspending an active agent. The nonaqueous, single-phase vehicle includes at least one solvent and at least one polymer and is formulated to exhibit phase separation upon contact with an aqueous environment. The at least one solvent may be selected from the group consisting of benzyl benzoate, decanol, ethyl hexyl lactate, and mixtures thereof and the at least one polymer may be selected from the group consisting of a polyester, pyrrolidone, ester of an unsaturated alcohol, ether of an unsaturated alcohol, polyoxyethylenepolyoxypropylene block copolymer, and mixtures thereof. In one embodiment, the at least one solvent is benzyl benzoate and the at least one polymer is polyvinylpyrrolidone. A stable, nonaqueous suspension formulation that includes the nonaqueous, single-phase vehicle and an active agent, and a method of forming the same, are also disclosed.

The invention provides a method for preparing a titanium dioxide nano belt, belonging to the nano material technical field. The prior methods for preparing the titanium dioxide nano belt comprise the hydro-thermal method and the combination method of the sol-gel method and the hydro-thermal method. The prior electrostatic spinning method is applied to the preparation of nano fibers. The invention comprises three steps that: 1. a spinning solution is prepared; the mixture of polymethylmethacrylate and vinylpyrrolidone is used as a macromolecule template, and the mixture of chloroform and N,N-dimethylformamide is used as a solvent; 2. a titanium alkoxide/ macromolecule template compound nano belt is prepared; the electrostatic spinning method is used, and the technical parameters are as follows: the voltage is between 15 and 25kV and the curing distance is between 15 and 30cm; 3. a TiO2 nano belt is prepared; the heat treatment method is used, and the technical parameters are as follows: the rate of temperature rise is between 0.5 and 2 DEG C/min and the heat preservation time at the temperature of between 500 and 900 DEG C is between 10 and 15h; for the TiO2 nano belt prepared, the width is between 5 and 15mu m, the thickness is between 30 and 60nm and the length is more than 200mu m; the TiO2 nano belt comprises a pure phase anatase type TiO2 nano belt and a pure phase rutile type TiO2 nano belt.

The invention discloses a method for preparing nanometer silver lines in large batch. anhydrous silver nitrate AgNO3 with the concentration of 99.9percent, anhydrous glycol (C2H6O2) of 99.8percent and polyvinylpyrrolidone (PVP, with the molecular weight of 55,000) of 98percent are selected as the raw materials; in a microwave-assisting environment, the method of adopting the glycol to reduce the silver nitrate is adopted to prepare nanometer silver lines in large batch. By replacing the original solvent heating method with the high-heat environment created by microwave, the method not only greatly saves the reaction time but also reduces the preparing costs for the nanometer silver lines. The glycol, a moderate reducer, can slow the reaction, thus providing the time for the growth of nanometer silver lines. The method of the invention is the optimal method for preparing the nanometer silver line according to testing results by comparing the influence of micro strength, precursor concentration and microwave processing time on the appearance and size of the prepared nanometer lines. The method of the invention has low cost, is simple method and easily controlled and has high practical value in the application to the industrial production developing nanometer silver lines.

The polishing slurry of the invention is a polishing slurry for polishing a silicon oxide film on polysilicon, which contains an abrasive, polysilicon polishing inhibitor, and water. As the polishing inhibitor, it is preferable to use (1) a water-soluble polymer having a N-monosubstituted or N,N-disubstituted skeleton substituted by any member selected from the group consisting of acrylamide, methacrylamide, and α-substituted derivatives thereof, (2) polyethylene glycol, (3) an oxyethylene adduct of an acetylene-based diol, (4) a water-soluble organic compound having an acetylene bond, (5) an alkoxylated linear aliphatic alcohol, or (6) a copolymer containing polyvinyl pyrrolidone or vinyl pyrrolidone. There is provided a polishing method which is capable of polishing a silicon oxide film on a polysilicon film at a high speed, and inhibiting the progress of polishing of a polysilicon film in exposed parts in the manufacturing method for a semiconductor.

The present invention provides a composition alleviated in a bitter taste or the like of a medicament. The present invention relates to a composition comprising a basic medicament having an unpleasant taste and polyvinylpyrrolidone and/or copolyvidone; or a method for alleviating an unpleasant taste of a basic medicament having the unpleasant taste by adding polyvinylpyrrolidone and/or copolyvidone. The present invention further provides a composition comprising (1) a basic medicament, (2) polyvinylpyrrolidone and/or copolyvidone, and (3) propylene glycol and/or D-sorbitol; a composition comprising (1) a basic medicament, (2) polyvinylpyrrolidone and/or copolyvidone, and (4) an antioxidant; and a composition comprising (1) a basic medicament, (2) polyvinylpyrrolidone and/or copolyvidone, and (5) a colorant or flavor containing a sulfuric acid or sulfurous acid group.

The present invention provides an assembly for the preparation of a medical device having a porous coating comprising hydrogen peroxide. Particularly interesting medical devices are catheters (such as urinary catheters), endoscopes, laryngoscopes, tubes for feeding, tubes for drainage, guide wires, condoms, urisheaths, barrier coatings e.g. for gloves, stents and other implants, extra corporeal blood conduits, membranes e.g. for dialysis, blood filters, devices for circulatory assistance, dressings for wound care, and ostomy bags. The coating is in particular a hydrophilic coating formed from cross-linked polyvinylpyrrolidone. In one embodiment, the assembly holds a dry catheter element in one compartment of a package and an aqueous hydrogen peroxide solution in another compartment. The solution may also comprise stabilizers, e.g. chelators, and osmolality increasing agents. The catheter for insertion in the urethra is useful for the treatment, alleviation or prophylaxis of microbial infections such as urinary tract infections (UTI).

A polymer blend is prepared by dissolving chitosan and a second polymer in an acidic aqueous solution to form an aqueous polymer blend, dehydrating said aqueous polymer blend, and recovering said polymer blend. The second polymer may be selected from the group consisting of polyether glycols including polyethylene glycols; cellulose esters including cellulose acetate; poloxamers; polysaccharides including dextran and guar; polyvinylpyrrolidones; polyvinyl alcohols; and mixtures or copolymers thereof. These polymer blends swell in an acidic environment and deswell in a more neutral or basic environment. This technology is valuable for the dispensing of biologically active material or drugs into a surrounding environment, especially the environment as is found in the gastrointestinal tract. Since the various polymer blends of the present invention are not covalently or ionically crosslinked, but are physically combined, each polymer in the physical blend maintains its original chemical structure, and therefore, is safe for oral administration.

A method of preserving, storing and transplanting mammalian donor organs. The method includes the cooling of refrigeration preservation, loading pre-freezer preservation, cryopreservation and washing solutions at least containing polyvinylpyrrolidone, a calcium channel blocker, a nucleoside, potassium chloride, polyethylene glycol, at least one amino acid, and a steroid to a temperature of 2° to 4° C. and/or of 0° to 2° C., harvesting a donor organ, perfusing it with one or more of the solution, immersing it in one or more of the solutions and storing it at a temperature above 0° C. or at a temperatures below 0° C. The cryopreservation solution also contains cryopreservative agents. Preserved organs may be transplanted directly from refrigeration storage or from freezer storage by cooling the washing refrigeration preservation solutions to 2° to 4° C., perfusing the organ with washing solution and then preservation solution, and transplanting it.

The invnetion provides a preparation method for a graphene oxide/polyvinylidene fluoride composite ultrafiltration membrane and relates to the preparation method of the graphene oxide/polyvinylidene fluoride composite ultrafiltration membrane. The invention aims to solve the problem of poor hydrophilicity and stain resistance of the existing polyvinylidene fluoride ultrafiltration membrane. The method provided by the invention comprises the following steps of: 1. respectively adding graphene oxide, polyvinylpyrrolidone and polyvinylidene fluoride with N-methylpyrrolidone as solvent, heating and stirring to obtain casting membrane solution; 2. putting the casting membrane solution on a clean glass plate and scrapping to a certain thickness by a coating device, and then immersing distilled water, shedding and drying to obtain the graphene oxide/polyvinylidene fluoride composite ultrafiltration membrane. The preparation method provided by the invention can be applied to the fields of drinking water preparation, food industry, pharmaceutical industry, biotechnology, chemical process and environmental engineering.

An aqueous, viscoelastic fluid gelled with a viscoelastic surfactant (VES) is inhibited against hydrate formation with an effective amount of an additive that could be one or more halide salts of alkali metals and alkali earth metals, formate salts, alcohols, glycols, glycol amines, sugars, sugar alcohols, amidoamine oxides, polymers such as polyamines, polyvinylpyrrolidones and derivatives thereof, polyvinyl alcohols and derivatives thereof, polycaprolactams and derivatives thereof, hydroxyethylcellulose, and mixtures thereof. These fluids are inhibited against hydrate formation and may have increased viscosity as well. The additives may increase viscosity to the point where less VES is required to maintain a given viscosity. These inhibited, aqueous, viscoelastic fluids may be used as treatment fluids for subterranean hydrocarbon formations, such as in stimulation treatments, e.g. hydraulic fracturing fluids.

Dental bleaching compositions include a dental bleaching agent, a generally linear high molecular weight (i.e., greater than about 500,000) polyvinyl pyrrolidone (PVP) and/or polyethylene oxide (PEO) tissue adhesion agent included in amount that imparts a high level of adhesiveness, a rheology-modifying agent such as fumed silica or fumed alumina that reduces or eliminates stringiness otherwise caused by the high molecular weight PVP and/or PEO, and a solvent or carrier. Dental bleaching compositions may include carboxypolymethylene instead of or in addition to PVP and/or PEO, wherein the fumed silica or fumed alumina increases long-term rheological stability even in the presence of a high concentration of dental bleaching agent. Dental treatment devices including a barrier layer and a quantity of the dental bleaching composition positioned adjacent to the barrier layer.